| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:36 UTC |
|---|
| Update Date | 2021-09-14 14:57:58 UTC |
|---|
| HMDB ID | HMDB0013960 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Donepezil metabolite M4 |
|---|
| Description | Donepezil metabolite M4 is a metabolite of Donepezil. Donepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, and also marketed under the brand name DONEP by Alkem Pentacare, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the palliative treatment of Alzheimer's disease. Common side effects include gastrointestinal upset. It has an oral bioavailability of 100% and easily crosses the blood–brain barrier. Because it has a biological half-life of about 70 hours, it can be taken once a day. (Wikipedia) |
|---|
| Structure | COC1=C(OC)C=C2C(=O)C(CC3CCNCC3)CC2=C1 InChI=1S/C17H23NO3/c1-20-15-9-12-8-13(7-11-3-5-18-6-4-11)17(19)14(12)10-16(15)21-2/h9-11,13,18H,3-8H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (2S,3R,4E)-2-Alkanamido-3-hydroxyoctadec-4-en-1-yl 3-O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-beta-D-galactopyranoside | HMDB | | (2S,3R,4E)-2-Alkanamido-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2Right3)-beta-D-galactopyranoside | HMDB | | (Acetyloxy)(tributyl)stannane (acd/name 4.0) | HMDB | | (Acetyloxy)tributyl-stannane | HMDB | | (Gal)1 (neu5ac)1 (cer)1 | HMDB | | Acetoxytributyl-stannane | HMDB | | Acetoxytributyl-tin | HMDB | | Acetoxytributylstannane | HMDB | | Acetoxytributyltin | HMDB | | alpha-Neu5ac-(2Right3)-beta-D-gal-(1leftright1')-cer | HMDB | | alpha-Neup5ac-(2Right3)-beta-D-galp-(1leftright1')-cer | HMDB | | Ganglioside GM4 | HMDB | | GM4 | HMDB | | N-Acetyl-alpha-neuraminosyl-(2Right3)-beta-D-galactosylceramides | HMDB | | N-Acetylneuraminyl-galactosylceramide | HMDB | | Neu5ac-alpha2->3gal-beta1->1'cer | HMDB | | Neu5ac-gal-beta1->1'cer | HMDB | | NeuAcalpha2-3galbeta-cer | HMDB | | TBTA | HMDB | | Tin, tributyl-, acetate | HMDB | | Tri-N-butyltin acetate | HMDB | | Tributylacetoxystannane | HMDB | | Tributylstannyl acetate | HMDB | | Tributyltin acetate | HMDB | | Tribuyltin acetate | HMDB |
|
|---|
| Chemical Formula | C17H23NO3 |
|---|
| Average Molecular Weight | 289.3694 |
|---|
| Monoisotopic Molecular Weight | 289.167793607 |
|---|
| IUPAC Name | 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one |
|---|
| Traditional Name | 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydroinden-1-one |
|---|
| CAS Registry Number | 56-36-0 |
|---|
| SMILES | COC1=C(OC)C=C2C(=O)C(CC3CCNCC3)CC2=C1 |
|---|
| InChI Identifier | InChI=1S/C17H23NO3/c1-20-15-9-12-8-13(7-11-3-5-18-6-4-11)17(19)14(12)10-16(15)21-2/h9-11,13,18H,3-8H2,1-2H3 |
|---|
| InChI Key | PGBZORAISITZTF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as indanones. Indanones are compounds containing an indane ring bearing a ketone group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Indanes |
|---|
| Sub Class | Indanones |
|---|
| Direct Parent | Indanones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Indanone
- Anisole
- Aryl ketone
- Aryl alkyl ketone
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Ketone
- Secondary aliphatic amine
- Ether
- Secondary amine
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Amine
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 84.7 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.065 mg/mL | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.71 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.1128 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.31 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1202.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 201.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 151.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 171.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 92.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 279.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 340.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 561.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 772.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 313.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1006.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 223.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 264.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 577.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 428.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 119.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Donepezil metabolite M4,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C)CC1)C2 | 2609.1 | Semi standard non polar | 33892256 | | Donepezil metabolite M4,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C)CC1)C2 | 2702.8 | Standard non polar | 33892256 | | Donepezil metabolite M4,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C)CC1)C2 | 3343.1 | Standard polar | 33892256 | | Donepezil metabolite M4,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C(C)(C)C)CC1)C2 | 2855.3 | Semi standard non polar | 33892256 | | Donepezil metabolite M4,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C(C)(C)C)CC1)C2 | 2924.6 | Standard non polar | 33892256 | | Donepezil metabolite M4,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C(C)(C)C)CC1)C2 | 3499.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Donepezil metabolite M4 GC-MS (Non-derivatized) - 70eV, Positive | splash10-008a-7390000000-30b373dbaf089a113774 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Donepezil metabolite M4 GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Positive-QTOF | splash10-0006-0090000000-da28a41bd1b829d71a8e | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Positive-QTOF | splash10-0bu3-4970000000-801d3c0b32c93fd11165 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Positive-QTOF | splash10-0a59-9510000000-6d1d9c2e6a3d68e3dff0 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Negative-QTOF | splash10-000i-0090000000-e07661d76997ea63c579 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Negative-QTOF | splash10-000i-1190000000-7f3cb62ab8e739b13f28 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Negative-QTOF | splash10-005l-2960000000-4aff8e96600a8dcc0cd7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Negative-QTOF | splash10-000i-0090000000-1f5244541851cecc3419 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Negative-QTOF | splash10-000i-0090000000-ea661d63d95f0276ff50 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Negative-QTOF | splash10-017i-0190000000-bbc4b50b5f9509e31d35 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Positive-QTOF | splash10-0006-0090000000-33b322e33c44f750998f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Positive-QTOF | splash10-0006-0090000000-a157f4737fa76857bd9f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Positive-QTOF | splash10-08g4-2960000000-aa5279093d72dcc7f374 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|